Hong Kong stocks were volatile | Bokang Vision Cloud-B (02592.HK) fell nearly 15% at one point. CBT-199, an ophthalmic drug candidate, submitted a new drug clinical trial application in the United States.

According to the Wisdom Financial APP, Bokang Cloud-B (02592.HK) fell nearly 15% at one point, and has since retreated by over 40% from December 5th. It is worth noting that the stock saw a significant surge from November 21st to December 4th, with the stock price doubling in just 10 trading days. As of the time of writing, it has fallen by 11.59% to 4.96 Hong Kong dollars, with a trading volume of 6.7798 million Hong Kong dollars.